Business Description
HPGC Renmintongtai Pharmaceutical Corp
ISIN : CNE000000G05
Share Class Description:
SHSE:600829: Class ATotal Employee Number:
2,735Compare
Compare
Traded in other countries / regions
600829.China Index Membership
SSE Composite Index IPO Date
1994-02-24Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.17 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 3.47 | |||||
Interest Coverage | 12.59 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.19 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.5 | |||||
3-Year EBITDA Growth Rate | -15.6 | |||||
3-Year EPS without NRI Growth Rate | -19.4 | |||||
3-Year FCF Growth Rate | -2 | |||||
3-Year Book Growth Rate | 7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.46 | |||||
9-Day RSI | 53.76 | |||||
14-Day RSI | 53.79 | |||||
3-1 Month Momentum % | -16.31 | |||||
6-1 Month Momentum % | -26.3 | |||||
12-1 Month Momentum % | -19.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.66 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 43.47 | |||||
Days Sales Outstanding | 146.28 | |||||
Days Payable | 105.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 3.42 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.3 | |||||
Operating Margin % | 2.89 | |||||
Net Margin % | 1.3 | |||||
EBITDA Margin % | 2.06 | |||||
FCF Margin % | 2.33 | |||||
OCF Margin % | 2.5 | |||||
ROE % | 4.56 | |||||
ROA % | 1.91 | |||||
ROIC % | 6.99 | |||||
3-Year ROIIC % | 390.05 | |||||
ROC (Joel Greenblatt) % | 8.54 | |||||
ROCE % | 6.94 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 38.18 | |||||
PE Ratio without NRI | 27.81 | |||||
Shiller PE Ratio | 21.45 | |||||
Price-to-Owner-Earnings | 42.31 | |||||
PS Ratio | 0.51 | |||||
PB Ratio | 1.71 | |||||
Price-to-Tangible-Book | 1.72 | |||||
Price-to-Free-Cash-Flow | 21.19 | |||||
Price-to-Operating-Cash-Flow | 19.8 | |||||
EV-to-EBIT | 23.43 | |||||
EV-to-EBITDA | 23.43 | |||||
EV-to-Revenue | 0.48 | |||||
EV-to-FCF | 20.73 | |||||
Price-to-GF-Value | 1.15 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-Median-PS-Value | 1.02 | |||||
Price-to-Graham-Number | 1.46 | |||||
| Price-to-Net-Current-Asset-Value | 2.02 | |||||
Earnings Yield (Greenblatt) % | 4.27 | |||||
FCF Yield % | 4.71 | |||||
Forward Rate of Return (Yacktman) % | -6.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HPGC Renmintongtai Pharmaceutical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 10,535.724 | ||
| EPS (TTM) (Â¥) | 0.236 | ||
| Beta | 0.5989 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.28 | ||
| Volatility % | 56.6 | ||
| 14-Day RSI | 53.79 | ||
| 14-Day ATR (Â¥) | 0.516728 | ||
| 20-Day SMA (Â¥) | 8.4655 | ||
| 12-1 Month Momentum % | -19.19 | ||
| 52-Week Range (Â¥) | 7.54 - 18.13 | ||
| Shares Outstanding (Mil) | 579.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HPGC Renmintongtai Pharmaceutical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HPGC Renmintongtai Pharmaceutical Corp Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.144000 Cash Dividend | 2024-07-25 | 5.61 (+0.72%) | ||
| 1.5:1 Stock Split | 2011-06-14 | 13.15 (+1.39%) | ||
| 1.5:1 Stock Split | 2004-08-25 | 4.09 (-1.18%) | ||
| 1.5:1 Stock Split | 2002-10-23 | 4.79 (-0.31%) | ||
| 1.3:1 Stock Split | 2002-07-02 | 4.40 (+1.63%) | ||
| 1.1:1 Stock Split | 1997-07-07 | 1.08 (+0.19%) | ||
| 1.1:1 Stock Split | 1996-06-17 | 0.97 (-2.28%) | ||
| 1.1:1 Stock Split | 1995-05-29 | 1.16 (+4.45%) |
Show
Entries
HPGC Renmintongtai Pharmaceutical Corp Frequently Asked Questions
What is HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829)'s stock price today?
The current price of SHSE:600829 is ¥9.01. The 52 week high of SHSE:600829 is ¥18.13 and 52 week low is ¥7.54.
When is next earnings date of HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829)?
The next earnings date of HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829) is .
Does HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829) pay dividends? If so, how much?
HPGC Renmintongtai Pharmaceutical Corp(SHSE:600829) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on HPGC Renmintongtai Pharmaceutical Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers